title: Genotypic interaction and gender specificity of common genetic variants in the p53/mdm2 network in Crohn's disease.
abstract: OBJECTIVE
  Defective p53-mediated apoptosis and cell cycle control have been implicated in the immunopathogenesis of Crohn's disease (CD). Since common functional variants of p53 (SNP72 G/C) and its key negative regulator mdm2 (SNP309 T/G) have been reported to affect cellular apoptotic and cell cycle arrest capacities, we assessed the effects of these variants on CD susceptibility and their relationship to NOD2/CARD15 as a well-established genetic CD risk factor.
  
  
  METHODS
  The variants SNP72 G/C and SNP309 T/G were genotyped in 149 European CD patients and 478 healthy controls. Subgroup analysis was performed in relation to NOD2/CARD15 status and to demographic/clinical characteristics.
  
  
  RESULTS
  The p53 SNP72 CC genotype tended to be less frequent in CD. This reached statistical significance only in the male cohort (0 vs. 7.3%; p = 0.037). Genotype and allele frequencies of both single-nucleotide polymorphisms (SNPs) were otherwise not significantly different. In the combined genotypic analysis, the genotype p53 SNP72 CC was significantly underrepresented in mdm2 SNP309 TT homozygotes (0 vs. 9.7%; p = 0.034). No association was observed between NOD2/CARD15 and the respective SNPs.
  
  
  CONCLUSIONS
  We report on a gender-specific protective effect of the low-apoptotic SNP72 CC genotype, and a gender-unrestricted genotypic interaction between SNP309 TT and SNP72 CC, which, for the first time, links sequence variation of the p53/mdm2 network to CD, independent of NOD2/CARD15.
authors.affiliation: Department of Medicine II, Saarland University Hospital, Homburg/Saar, Germany.
authors.forename: V
authors.initials: V
authors.lastname: Zimmer
authors.forename: T
authors.initials: T
authors.lastname: Widmann
authors.forename: M
authors.initials: M
authors.lastname: Müller
authors.forename: M F
authors.initials: MF
authors.lastname: Ong
authors.forename: J M
authors.initials: JM
authors.lastname: Stein
authors.forename: M
authors.initials: M
authors.lastname: Pfreundschuh
authors.forename: F
authors.initials: F
authors.lastname: Lammert
authors.forename: K
authors.initials: K
authors.lastname: Roemer
authors.forename: G
authors.initials: G
authors.lastname: Assmann
mesh_terms: D000328:Adult; D000483:Alleles; D017209:Apoptosis / Q000235:genetics*; D016022:Case-Control Studies; D016001:Confidence Intervals; D003424:Crohn Disease / Q000453:epidemiology / Q000235:genetics* / Q000473:pathology; D005260:Female; D005786:Gene Expression Regulation; D020022:Genetic Predisposition to Disease; D014644:Genetic Variation; D005838:Genotype; D006801:Humans; D008297:Male; D008875:Middle Aged; D016017:Odds Ratio; D020641:Polymorphism, Single Nucleotide; D011379:Prognosis; D051736:Proto-Oncogene Proteins c-mdm2 / Q000235:genetics*; D012016:Reference Values; D018570:Risk Assessment; D012737:Sex Factors; D016159:Tumor Suppressor Protein p53 / Q000235:genetics*
chemical_list: D016159:Tumor Suppressor Protein p53; C497206:MDM2 protein, human; D051736:Proto-Oncogene Proteins c-mdm2